Kristen Nields

Kristen Nields started her scientific career at SmithKline Beecham and joined Janssen in 2002 as part of the PRD DMPK organization utilizing LC/MS for FIH metabolite ID. In 2007, she received a technology innovation award from Janssen for her efforts developing a rapid cohesive LC/MS method for first-in-human metabolite identification.

In 2007 Kristen left JNJ and worked at both Merck and GSK while obtaining her Ph.D. from the University of Sciences in Philadelphia. In 2014 she rejoined the Janssen organization and in 2020 moved into the cell line engineering and early development organization (CEED). Within CEED Kristen has taken on a role in the newly established cross-divisional E2E team supporting internal programs as a Senior Scientist. She was also selected to be the CDS analytical liaison to partner companies supporting externalized CLD programs.

Kristen is a member of the external industry interest groupBioPhorumon the analytical subgroup and presents scientific results both inside and outside of the company at national conferences.